EUVIMEDEUVIMED entdecken
Crossref

Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in Italy

Fiorenza De Rose, Sara Lucidi, Elisabetta Bonzano, Maria Carmen De Santis, Bruno Meduri, Riccardo Ray Colciago, Agnese Prisco, Samantha Dicuonzo, Eliana La Rocca, Nadia Pasinetti, Isabella Palumbo, Icro Meattini und 2 weitere

Clinical and Translational Oncology · 2026

DOI: 10.1007/s12094-026-04360-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2026. Verfasst von Fiorenza De Rose und 13 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology, Azienda Sanitaria Universitaria Integrata del Trentino (ASUIT), Trento, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Lymph Node Excision, Practice Patterns, Physicians'. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess the current practices concerning the axillary management of clinically node-positive (cN +) breast cancer (BC) patients undergoing neoadjuvant chemotherapy (NAC), among radiation oncologists (ROs) practicing in Italy. METHODS: An online 24-question survey was distributed via SurveyMonkey to ROs between December 2024 and February 2025. This survey was developed through a multistep process by the Clinical Oncology Breast Cancer Group (COBCG) and AIRO Breast Cancer study groups' experts, focusing on axillary lymph node dissection (ALND) omission after pathological complete response (pCR) and its implications for regional nodal irradiation (RNI). The survey followed the CHERRIES statement and ESTRO guidelines and was revised and approved by the scientific committee of AIRO (Nr. 21/2024). RESULTS: 119/195 (61%) Italian Radiotherapy Centers, mostly public hospitals, completed the survey. Regarding cN + disease at diagnosis and node-negative disease (ypN0) on sentinel lymph node biopsy (SLNB) after NAC, ALND was omitted a) always, b) when three sentinel nodes were removed, c) never, and d) only in selected cases, in 26.05%, 45.38%, 2.52% and 26.05%, respectively. Most respondents (80%) said ALND omission was a multidisciplinary decision. According to 48.60%, ALND was omitted in cN1 disease. RNI indications varied in patients not undergoing ALND. Among 70 respondents defining RNI target volumes in cN2-3 patients without ALND, 62.86% treated all nodal levels (I-IV). Key factors influencing RNI included pre-NAC lymph node burden (56.72%), extracapsular nodal extension (43.94%), and tumor size (40.63%). CONCLUSIONS: Axillary management of BC patients undergoing NAC in Italy is moving toward treatment de-escalation, with relevant variability, supporting the need for multidisciplinary harmonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapyLymph Node ExcisionPractice Patterns, Physicians'HumansFemaleItalySentinel Lymph Node BiopsyAxillaLymphatic MetastasisSurveys and QuestionnairesChemotherapy, AdjuvantLymph NodesPathologic Complete ResponseRadiation Oncologists

Stichwörter der Autor:innen

Axillary lymph node dissection (ALND)Breast cancerMultidisciplinary discussionNeoadjuvant chemotherapy (NAC)Regional node irradiation (RNI)Sentinel lymph node biopsy (SLNB)

Autor:innen und Institutionen

  • Radiation Oncology, Azienda Sanitaria Universitaria Integrata del Trentino (ASUIT), Trento, Italy.
  • Clinical Oncology Breast Cancer Group (COBCG), Florence, Italy.
  • Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. e.bonzano@smatteo.pv.it.
  • Clinical Oncology Breast Cancer Group (COBCG), Florence, Italy. e.bonzano@smatteo.pv.it.
  • Radiation Oncology, Fondazione IRCCS Istituto Nazionale Tumori Di Milano, Milan, Italy.
  • Proton Therapy Department, Azienda Sanitaria Universitaria Integrata del Trentino (ASUIT), Trento, Italy.

Zitieren

APA

De Rose, F., Lucidi, S., Bonzano, E., De Santis, M. C., Meduri, B., Colciago, R. R., Prisco, A., Dicuonzo, S., La Rocca, E., Pasinetti, N., Palumbo, I., Meattini, I., Franco, P., & Ippolito, E. (2026). Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in Italy. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04360-2

Vancouver

De Rose F, Lucidi S, Bonzano E, De Santis MC, Meduri B, Colciago RR, et al. Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in Italy. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04360-2

BibTeX
@article{DeRose2026,
  author = {De Rose, Fiorenza and Lucidi, Sara and Bonzano, Elisabetta and De Santis, Maria Carmen and Meduri, Bruno and Colciago, Riccardo Ray and Prisco, Agnese and Dicuonzo, Samantha and La Rocca, Eliana and Pasinetti, Nadia and Palumbo, Isabella and Meattini, Icro and Franco, Pierfrancesco and Ippolito, Edy},
  title = {Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in Italy},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04360-2}
}
Kostenlos starten →